HAX-1: A family of apoptotic regulators in health and disease

Journal of Cellular Physiology

Volumn 226, Issue 11, 2011, Pages 2752-2761

  Yap, Solomon V ^a   Koontz, Jason M ^a   Kontrogianni Konstantopoulos, Aikaterini ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HAX 1 PROTEIN; PROTEIN; UNCLASSIFIED DRUG;

BREAST CANCER; CANCER CELL; CANCER GROWTH; CELL ORGANELLE; CELLULAR DISTRIBUTION; COLON CANCER; CONGENITIAL NEUTROPENIA; DISEASE COURSE; DOWN REGULATION; GENERAL ASPECTS OF DISEASE; HEALTH; HUMAN; MAMMAL CELL; NEOPLASM; NEURAL TUBE DEFECT; NEUTROPENIA; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PSORIASIS; REVIEW; SKIN CANCER; UPREGULATION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; BREAST NEOPLASMS; CARRIER PROTEINS; CENTRAL NERVOUS SYSTEM; COLONIC NEOPLASMS; DOWN-REGULATION; FEMALE; GENE EXPRESSION PROFILING; HUMANS; MALE; MICE; NEUTROPENIA; PROTEIN ISOFORMS; PROTEINS; PSORIASIS; RATS; SKIN NEOPLASMS;

EID: 80051935850     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.22638     Document Type: Review

References (46)

1. Al-Maghrebi M, Brule H, Padkina M, Allen C, Holmes WM, Zehner ZE. 2002. The 3' untranslated region of human vimentin mRNA interacts with protein complexes containing eEF-1gamma and HAX-1. Nucleic Acids Res 30: 5017-5028.
2. Bowman AL, Catino DH, Strong JC, Randall WR, Kontrogianni-Konstantopoulos A, Bloch RJ. 2008. The rho-guanine nucleotide exchange factor domain of obscurin regulates assembly of titin at the Z-disk through interactions with Ran binding protein 9. Mol Biol Cell 19: 3782-3792.
3. Carlsson G, Melin M, Dahl N, Ramme KG, Nordenskjold M, Palmblad J, Henter JI, Fadeel B. 2007. Kostmann syndrome or infantile genetic agranulocytosis, part two: Understanding the underlying genetic defects in severe congenital neutropenia. Acta Paediatr 96: 813-819.
4. Carlsson G, van't Hooft I, Melin M, Entesarian M, Laurencikas E, Nennesmo I, Trebinska A, Grzybowska E, Palmblad J, Dahl N, Nordenskjold M, Fadeel B, Henter JI. 2008. Central nervous system involvement in severe congenital neutropenia: Neurological and neuropsychological abnormalities associated with specific HAX1 mutations. J Intern Med 264: 388-400.
5. Carlsson G, Elinder G, Malmgren H, Trebinska A, Grzybowska E, Dahl N, Nordenskjold M, Fadeel B. 2009. Compound heterozygous HAX1 mutations in a Swedish patient with severe congenital neutropenia and no neurodevelopmental abnormalities. Pediatr Blood Cancer 53: 1143-1146.
6. Chao JR, Parganas E, Boyd K, Hong CY, Opferman JT, Ihle JN. 2008. Hax1-mediated processing of HtrA2 by Parl allows survival of lymphocytes and neurons. Nature 452: 98-102.
7. Cho K, Adamson L, Park JH, Zipkin R, Greenhalgh D. 2002. Identification of truncated form of mouse HAX-1s gene (HAX-1xs) and characterization of its expression in small intestine and thymus of mice after burn injury. Shock 18: 223-229.
8. Cilenti L, Soundarapandian MM, Kyriazis GA, Stratico V, Singh S, Gupta S, Bonventre JV, Alnemri ES, Zervos AS. 2004. Regulation of HAX-1 anti-apoptotic protein by Omi/HtrA2 protease during cell death. J Biol Chem 279: 50295-50301.
9. Dufva M, Olsson M, Rymo L. 2001. Epstein-Barr virus nuclear antigen 5 interacts with HAX-1, a possible component of the B-cell receptor signalling pathway. J Gen Virol 82: 1581-1587.
10. Fadeel B, Grzybowska E. 2009. HAX-1: A multifunctional protein with emerging roles in human disease. Biochim Biophys Acta 1790: 1139-1148.
11. Fulda S, Debatin KM. 2004a. Apoptosis signaling in tumor therapy. Ann N Y Acad Sci 1028: 150-156.
12. Fulda S, Debatin KM. 2004b. Signaling through death receptors in cancer therapy. Curr Opin Pharmacol 4: 327-332.
13. Fulda S, Debatin KM. 2004c. Targeting apoptosis pathways in cancer therapy. Curr Cancer Drug Targets 4: 569-576.
14. Gallagher AR, Cedzich A, Gretz N, Somlo S, Witzgall R. 2000. The polycystic kidney disease protein PKD2 interacts with Hax-1, a protein associated with the actin cytoskeleton. Proc Natl Acad Sci USA 97: 4017-4022.
15. Germeshausen M, Grudzien M, Zeidler C, Abdollahpour H, Yetgin S, Rezaei N, Ballmaier M, Grimbacher B, Welte K, Klein C. 2008. Novel HAX1 mutations in patients with severe congenital neutropenia reveal isoform-dependent genotype-phenotype associations. Blood 111: 4954-4957.
16. Grzybowska EA, Sarnowska E, Konopinski R, Wilczynska A, Sarnowski TJ, Siedlecki JA. 2006. Identification and expression analysis of alternative splice variants of the rat Hax-1 gene. Gene 371: 84-92.
17. Han Y, Chen YS, Liu Z, Bodyak N, Rigor D, Bisping E, Pu WT, Kang PM. 2006. Overexpression of HAX-1 protects cardiac myocytes from apoptosis through caspase-9 inhibition. Circ Res 99: 415-423.
18. Hippe A, Bylaite M, Chen M, von Mikecz A, Wolf R, Ruzicka T, Walz M. 2006. Expression and tissue distribution of mouse Hax1. Gene 379: 116-126.
19. Ishikawa N, Okada S, Miki M, Shirao K, Kihara H, Tsumura M, Nakamura K, Kawaguchi H, Ohtsubo M, Yasunaga S, Matsubara K, Sako M, Hara J, Shiohara M, Kojima S, Sato T, Takihara Y, Kobayashi M. 2008. Neurodevelopmental abnormalities associated with severe congenital neutropenia due to the R86X mutation in the HAX1 gene. J Med Genet 45: 802-807.
20. Jeyaraju DV, Cisbani G, De Brito OM, Koonin EV, Pellegrini L. 2009. Hax1 lacks BH modules and is peripherally associated to heavy membranes: Implications for Omi/HtrA2 and PARL activity in the regulation of mitochondrial stress and apoptosis. Cell Death Differ 16: 1622-1629.
21. Jiang Y, Zhang W, Kondo K, Klco JM, St Martin TB, Dufault MR, Madden SL, Kaelin WG Jr, Nacht M. 2003. Gene expression profiling in a renal cell carcinoma cell line: Dissecting VHL and hypoxia-dependent pathways. Mol Cancer Res 1: 453-462.
22. Kang YJ, Jang M, Park YK, Kang S, Bae KH, Cho S, Lee CK, Park BC, Chi SW, Park SG. 2010. Molecular interaction between HAX-1 and XIAP inhibits apoptosis. Biochem Biophys Res Commun 393: 794-799.
23. Kawaguchi Y, Nakajima K, Igarashi M, Morita T, Tanaka M, Suzuki M, Yokoyama A, Matsuda G, Kato K, Kanamori M, Hirai K. 2000. Interaction of Epstein-Barr virus nuclear antigen leader protein (EBNA-LP) with HS1-associated protein X-1: Implication of cytoplasmic function of EBNA-LP. J Virol 74: 10104-10111.
24. Klein C, Grudzien M, Appaswamy G, Germeshausen M, Sandrock I, Schaffer AA, Rathinam C, Boztug K, Schwinzer B, Rezaei N, Bohn G, Melin M, Carlsson G, Fadeel B, Dahl N, Palmblad J, Henter JI, Zeidler C, Grimbacher B, Welte K. 2007. HAX1 deficiency causes autosomal recessive severe congenital neutropenia (Kostmann disease). Nat Genet 39: 86-92.
25. Laporte M, Galand P, Fokan D, de Graef C, Heenen M. 2000. Apoptosis in established and healing psoriasis. Dermatology 200: 314-316.
26. Lee AY, Lee Y, Park YK, Bae KH, Cho S, Lee do H, Park BC, Kang S, Park SG. 2008. HS 1-associated protein X-1 is cleaved by caspase-3 during apoptosis. Mol Cells 25: 86-90.
27. Lees DM, Hart IR, Marshall JF. 2008. Existence of multiple isoforms of HS1-associated protein X-1 in murine and human tissues. J Mol Biol 379: 645-655.
28. Li WB, Feng J, Geng SM, Zhang PY, Yan XN, Hu G, Zhang CQ, Shi BJ. 2009. Induction of apoptosis by Hax-1 siRNA in melanoma cells. Cell Biol Int 33: 548-554.
29. Mamishi S, Esfahani SA, Parvaneh N, Diestelhorst J, Rezaei N. 2009. Severe congenital neutropenia in 2 siblings of consanguineous parents. The role of HAX1 deficiency. J Investig Allergol Clin Immunol 19: 500-503.
30. Matsubara K, Imai K, Okada S, Miki M, Ishikawa N, Tsumura M, Kato T, Ohara O, Nonoyama S, Kobayashi M. 2007. Severe developmental delay and epilepsy in a Japanese patient with severe congenital neutropenia due to HAX1 deficiency. Haematologica 92: e123-e125.
31. Mirmohammadsadegh A, Tartler U, Michel G, Baer A, Walz M, Wolf R, Ruzicka T, Hengge UR. 2003. HAX-1, identified by differential display reverse transcription polymerase chain reaction, is overexpressed in lesional psoriasis. J Invest Dermatol 120: 1045-1051.
32. Ortiz DF, Moseley J, Calderon G, Swift AL, Li S, Arias IM. 2004. Identification of HAX-1 as a protein that binds bile salt export protein and regulates its abundance in the apical membrane of Madin-Darby canine kidney cells. J Biol Chem 279: 32761-32770.
33. Radhika V, Onesime D, Ha JH, Dhanasekaran N. 2004. Galpha13 stimulates cell migration through cortactin-interacting protein Hax-1. J Biol Chem 279: 49406-49413.
34. Ramsay AG, Keppler MD, Jazayeri M, Thomas GJ, Parsons M, Violette S, Weinreb P, Hart IR, Marshall JF. 2007. HS1-associated protein X-1 regulates carcinoma cell migration and invasion via clathrin-mediated endocytosis of integrin alphavbeta6. Cancer Res 67: 5275-5284.
35. Rhodes DR, Yu J, Shanker K, Deshpande N, Varambally R, Ghosh D, Barrette T, Pandey A, Chinnaiyan AM. 2004. ONCOMINE: A cancer microarray database and integrated data-mining platform. Neoplasia 6: 1-6.
36. Sarnowska E, Grzybowska EA, Sobczak K, Konopinski R, Wilczynska A, Szwarc M, Sarnowski TJ, Krzyzosiak WJ, Siedlecki JA. 2007. Hairpin structure within the 3'UTR of DNA polymerase beta mRNA acts as a post-transcriptional regulatory element and interacts with Hax-1. Nucleic Acids Res 35: 5499-5510.
37. Sharp TV, Wang HW, Koumi A, Hollyman D, Endo Y, Ye H, Du MQ, Boshoff C. 2002. K15 protein of Kaposi's sarcoma-associated herpesvirus is latently expressed and binds to HAX-1, a protein with antiapoptotic function. J Virol 76: 802-816.
38. Suzuki Y, Demoliere C, Kitamura D, Takeshita H, Deuschle U, Watanabe T. 1997. HAX-1, a novel intracellular protein, localized on mitochondria, directly associates with HS1, a substrate of Src family tyrosine kinases. J Immunol 158: 2736-2744.
39. Trebinska A, Rembiszewska A, Ciosek K, Ptaszynski K, Rowinski S, Kupryjanczyk J, Siedlecki JA, Grzybowska EA. 2010. HAX-1 overexpression, splicing and cellular localization in tumors. BMC Cancer 10: 76.
40. Vafiadaki E, Sanoudou D, Arvanitis DA, Catino DH, Kranias EG, Kontrogianni-Konstantopoulos A. 2007. Phospholamban interacts with HAX-1, a mitochondrial protein with anti-apoptotic function. J Mol Biol 367: 65-79.
41. Vafiadaki E, Arvanitis DA, Pagakis SN, Papalouka V, Sanoudou D, Kontrogianni-Konstantopoulos A, Kranias EG. 2009. The Anti-apoptotic protein HAX-1 interacts with SERCA2 and regulates its protein levels to promote cell survival. Mol Biol Cell 20: 306-318.
42. Viktorsson K, Ekedahl J, Lindebro MC, Lewensohn R, Zhivotovsky B, Linder S, Shoshan MC. 2003. Defective stress kinase and Bak activation in response to ionizing radiation but not cisplatin in a non-small cell lung carcinoma cell line. Exp Cell Res 289: 256-264.
43. Welter JF, Crish JF, Agarwal C, Eckert RL. 1995. Fos-related antigen (Fra-1), junB, and junD activate human involucrin promoter transcription by binding to proximal and distal AP1 sites to mediate phorbol ester effects on promoter activity. J Biol Chem 270: 12614-12622.
44. Yap SV, Vafiadaki E, Strong J, Kontrogianni-Konstantopoulos A. 2010. HAX-1: A multifaceted antiapoptotic protein localizing in the mitochondria and the sarcoplasmic reticulum of striated muscle cells. J Mol Cell Cardiol 48: 1266-1279.
45. Yedavalli VS, Shih HM, Chiang YP, Lu CY, Chang LY, Chen MY, Chuang CY, Dayton AI, Jeang KT, Huang LM. 2005. Human immunodeficiency virus type 1 Vpr interacts with antiapoptotic mitochondrial protein HAX-1. J Virol 79: 13735-13746.
46. Zhao W, Waggoner JR, Zhang ZG, Lam CK, Han P, Qian J, Schroder PM, Mitton B, Kontrogianni-Konstantopoulos A, Robia SL, Kranias EG. 2009. The anti-apoptotic protein HAX-1 is a regulator of cardiac function. Proc Natl Acad Sci USA 106: 20776-20781.